Odu Digital Commonsmetadata only
Depemokimab: A Twice Yearly Anti-IL 5 Biologic for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - A Narrative Review
humans, antibodies, monoclonal, humanized/administration & dosage/pharmacokinetics/adverse effects/therapeutic use, chronic disease/drug therapy, clinical trials, phase iii as topic, eosinophils/drug effects
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 351836
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.